Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Schellinger

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
European Neurology|December 21, 2006
Prognostic relevance of early MRI vessel signs is highly overrated--part 2Peter D Schellinger, Martin Köhrmann
The Lancet. Neurology|December 29, 2004
Stroke: advances in therapyPeter D Schellinger, Werner Hacke
Expert Review of Neurotherapeutics|February 1, 2012
Current acute stroke trials and their potential impact on the therapeutic time windowPeter D Schellinger, Martin Köhrmann
Stroke|February 15, 2014
4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmlyPeter D Schellinger, Martin Köhrmann
Stroke|July 19, 2008
MRA/DWI mismatch: a novel concept or something one could get easier and cheaper?Peter D Schellinger, Martin Köhrmann
Radiology|May 29, 2009
Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro MR imagingMartin Köhrmann, Peter D Schellinger
Cerebrovascular Diseases (Basel, Switzerland)|November 25, 2006
Symptomatic intracranial hemorrhage after thrombolysisMartin Köhrmann, Peter D Schellinger
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Stroke-MRI: extending the time-window: recent trials and clinical practiceMartin Köhrmann, Peter D Schellinger
Circulation|January 5, 2012
Letter to the editor by Köhrmann and Schellinger regarding article, "Current status of endovascular stroke treatment"Martin Köhrmann, Peter D Schellinger
Stroke|October 30, 2010
Pro: intravenous tissue plasminogen activator in stroke patients with rapid, complete recovery during evaluation (transient ischemic attack) and evidence of middle cerebral artery occlusionMartin Köhrmann, Peter D Schellinger
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
European Neurology|December 21, 2006
Prognostic relevance of early MRI vessel signs is highly overrated--part 2Peter D Schellinger, Martin Köhrmann
The Lancet. Neurology|December 29, 2004
Stroke: advances in therapyPeter D Schellinger, Werner Hacke
Expert Review of Neurotherapeutics|February 1, 2012
Current acute stroke trials and their potential impact on the therapeutic time windowPeter D Schellinger, Martin Köhrmann
Stroke|February 15, 2014
4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmlyPeter D Schellinger, Martin Köhrmann
Stroke|July 19, 2008
MRA/DWI mismatch: a novel concept or something one could get easier and cheaper?Peter D Schellinger, Martin Köhrmann
Radiology|May 29, 2009
Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro MR imagingMartin Köhrmann, Peter D Schellinger
Cerebrovascular Diseases (Basel, Switzerland)|November 25, 2006
Symptomatic intracranial hemorrhage after thrombolysisMartin Köhrmann, Peter D Schellinger
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Stroke-MRI: extending the time-window: recent trials and clinical practiceMartin Köhrmann, Peter D Schellinger
Circulation|January 5, 2012
Letter to the editor by Köhrmann and Schellinger regarding article, "Current status of endovascular stroke treatment"Martin Köhrmann, Peter D Schellinger
Stroke|October 30, 2010
Pro: intravenous tissue plasminogen activator in stroke patients with rapid, complete recovery during evaluation (transient ischemic attack) and evidence of middle cerebral artery occlusionMartin Köhrmann, Peter D Schellinger
Pageof 20